| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $132.9M | — | +4158.5% |
| R&D Expense | $12.6M | — | +80.5% |
| SG&A Expense | $46.9M | — | +56.1% |
| Operating Income | $61.5M | — | +273.6% |
| Pre-tax Income | $56.8M | — | +248.0% |
| Income Tax | $3.9M | — | — |
| Net Income | $52.9M | — | +237.8% |
| EPS (Basic) | $0.60 | — | +233.3% |
| EPS (Diluted) | $0.52 | — | +215.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $222.8M | +16.8% | +31.2% |
| Accounts Receivable | $74.2M | +37.1% | +5846.8% |
| Inventory | $28.5M | +19.8% | +2013.1% |
| Current Assets | $333.1M | +21.8% | +87.9% |
| Total Assets | $401.5M | +22.4% | +76.6% |
| Current Liabilities | $149.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $53.0M | — | +272.7% |
| Capital Expenditures | $2.8M | — | +757.6% |
| Investing Cash Flow | -$2.8M | — | -757.6% |
| Financing Cash Flow | -$18.1M | — | -174.3% |
| Free Cash Flow | $50.2M | — | +261.8% |
| +147.4% |
| Total Liabilities | $293.0M | +3.4% | +64.8% |
| Stockholders' Equity | $108.6M | +142.6% | +118.4% |